|
|
Article: EndoTex Interventional Systems Announces European Approval of Novel Carotid Stent Delivery System; Innovative Self-Expanding Stent Delivery System Designed Specifically for the Treatment of Patients with Carotid Artery Disease.
- Article from:
- PR Newswire
- Article date:
- April 13, 2005
CopyrightCOPYRIGHT 2005 PR Newswire Association LLC. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
CUPERTINO, Calif., April 13 /PRNewswire/ -- EndoTex Interventional Systems, Inc. (EndoTex) today announced Conformite Europeenne (CE) Mark approval of its NexStent(TM) Carotid Stent and Monorail(TM) Delivery System. The company's NexStent Carotid Stent System provides a minimally invasive approach for treating carotid artery disease, avoiding the more invasive surgical procedure called carotid endarterectomy (CEA).
"The results from CABERNET suggest that CAS in this high-risk patient subset appears competitive with the major CEA trials. This Innovative, sleek design delivered impressive results; a no nonsense, one size fits all stent," said Subbarao Myla, M.D., ...